Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 49

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 49
---
,031.03  
     1,017.41 
  
    Total Operating Expenses 
     1,280.26  
     1,336.48 

    Loss from Operations 
     (1,168.36) 
     (1,270.37)

    Interest Expense 
     (1.09) 
     (1.33)
  
    Change in Fair Value of Derivative Liabilities 
     3.12  
     1,647.37 
  
    Other Income, net 
     18.54  
     29.38 
  
    Total Interest and Other Income, net 
     20.57  
     1,675.43 
  
    (Loss) Income from Operations before Provision for Income Taxes 
     (1,147.79) 
     405.06 
  
    Provision for Income Taxes 
     0.04  
     0.06 
  
    Net (Loss) Income including Noncontrolling Interest 
     (1,147.83) 
     405.01 
  
    Net Loss – Noncontrolling Interest 
     (0.46) 
     (2.35)
  
    Net (Loss) Income – attributed to 60 Degrees Pharmaceuticals, Inc. 
     (1,147.37)% 
     407.36%

28

Comparison of the Three Months Ended March
31, 2025 and 2024

Product Revenues - net of Discounts and
Rebates, Cost of Revenues, Gross Profit, and Gross Margin

    For the Three Months Ended March 31,  

    Consolidated Statements of Operations Data: 
    2025  
    2024  
    $ Change  
    % Change 
  
    Product Revenues – net of Discounts and Rebates 
    $163,552  
    $105,674  
    $57,878  
     54.77%
  
    Cost of Revenues 
     73,272  
     65,437  
     7,835  
     11.97 
  
    Gross Profit 
    $90,280  
    $40,237  
    $50,043  
     124.37%
  
    Gross Margin % 
     55.20% 
     38.08% 

Product Revenues - net of Discounts